1 February 2017

New Approaches in Medicinal Chemistry ll

Organised by:

SCI's Young Chemists' Panel

Windlesham, Surrey

Registration Closed

This event is no longer available for registration.

Synopsis
This one day symposium is to be held at one of Eli Lilly’s major research and development centres in Windlesham, aimed at introducing and reviewing a wide range of hot topics and approaches towards discovering the drugs of tomorrow. By bringing together speakers from the key global centres of excellence in drug discovery, the day has been designed to deliver what is current and of high interest to those pushing forward the frontiers of drug discovery.
Attendees
The meeting is aimed at scientists in the industrial and academic fields with a background in medicinal chemistry or drug discovery. It is ideally suited to those studying for a postgraduate degree or working in the pharmaceutical or biotechnology industry.
Programme

Day 1 - 1st February 2017

Day schedule
09:00
Registration and refreshments
09:45
Welcome and introduction.
09:50
Selective depletion of pathogenic cells using heterobivalent small molecules - Brandon Turunen, GSK
10:25
Induced protein degradation - small synthetic molecules acting as enzymes - Chris Tame, GSK
11:00
Refreshment break
11:30
Affinity Directed Automated Synthesis (ADAS): A novel way of accelerating lead generation - J. Alfredo Martin, Eli Lilly
12:05
Enabling Science using innovative automation and data management technologies - Carolina Alhambra, Eli Lilly
12:40
Lunch
13:40
Fragment based drug discovert at Astex - Alison Woolford, Astex
14:15
The shifting landscape of structure based drug design through developments in electron microscopy - Stephen Muench, University of Leeds
14:50
Refreshments
15:20
A perspective on the next generation of antibacterial agenrts inspired by natural products - Pamela Brown, Cantab anti-infectives
15:55
Application of stem cell technology as a means of treating degenerative diseases - Yen Choo, Progenitor Therapeutic
16:30
End of event.
Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

Eli Lilly & Co Ltd

Erl Wood Manor
Sunninghill Road
Windlesham, Surrey
GU20 6PH

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Fees

Early bird fees before Friday 16 December 2016

GB£90 . . . . . . . . . . . . . . . . . SCI Member 
GB£30 . . . . . . . . . . . . . . . . . SCI Student Member
GB£120 . . . . . . . . . . . . . . . ..Non-Member

Standard fees after Friday 16 December 2016

GB£110 . . . . . . . . . . . . . . . . . SCI Member 
GB£35 . . . . . . . . . . . . . . . . . . SCI Student Member
GB£145 . . . . . . . . . . . . . . . . . Non-Member

SCI Platinum Corporate Members receive 25% off the above rates

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines
For booking terms and conditions click here.
CPD Info

SCI Members attending this meeting are able to claim CPD points.

Additional Info

Posters and Prizes

Interested applicants should send a maximum one page abstract including one figure or scheme to conferences@soci.org with the subject line ‘’New approaches in Medicinal Chemistry – poster submission’’ by Friday 9 December 2016. Prizes for academic and industrial posters will be awarded.

Exhibition

An exhibition will run alongside the conference during refreshment breaks, for companies and related organisations who may wish to exhibit. For further information and prices please email conferences@soci.org.

Academic Bursaries

Limited bursary places will be available to academic attendees with preference given to those presenting posters. To register your interest please email conferences@soci.org by Friday 9 December 2016.

Organisers

 Will Farnaby, SCI/Takeda Cambridge Ltd
Lewis Vidler, SCI/Eli Lilly
Kiri North, Vertex
Liz Jones, UCB
Ben Wittaker, CRL
Michael Lainchbury, CRL

Speakers

Confirmed speakers from: 
Astex, Cantab Anti-Infectives, Eli Lilly, GSK, Progenitor Therapeutics and The University of Leeds